Oral Immunotherapy for Egg Allergy in Children Aged 6 to 16
Egg Allergy
About this trial
This is an interventional treatment trial for Egg Allergy focused on measuring Oral immunotherapy, Egg allergy, Children
Eligibility Criteria
Inclusion Criteria: Age 6 to 16 years Elevated spesific serum IgE to egg (> 5 kU/l) and/or positive skin prick to egg allergen Positive oral food challenge for egg or anaphylaxis reaction to egg within the 6 months Diet free from egg in any form Exclusion Criteria: Age less than 6 years or more than 16 years Poor asthma control or uncontrolled asthma Severe/significant cardiovascular disease Autoimmune disease Malignancy Medication: beta bloker, angiotensin-converting-enzyme inhibitors (ACE inhibitors), Monoamine oxidase inhibitors (MAOIs) Poor compliance Fear of immunotherapy Desensitization to alfa-gal-protein (mammalian meat allergy)
Sites / Locations
- Oulu University HospitalRecruiting
- Tampere University HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Experimental
Experimental
No Intervention
No Intervention
Egg allergy with asthma with intervention
Egg allergy without asthma with intervention
Egg allergy with asthma without intervention
Egg allergy without asthma without intervention
Immunotherapy Egg product including egg white and yolk allergens
Immunotherapy Egg product including egg white and yolk allergens
No intervention, control
No intervention, control